#JSCAI
🫀 Stay up to date with the latest science in JSCAI. Explore new #InterventionalCardiology research, practical clinical insights, and official guideline updates from experts around the world—all fully Gold Open Access with no paywall.

Read the latest JSCAI issue ➡️ https://www.jscai.org/

#CardioSky
May 28, 2026 at 12:01 PM
The September issue of #JSCAI is now available. Explore new research, meta-analyses, and case reports covering cardiogenic shock, structural heart interventions, LAAO, and more.

Explore the issue ➡️ https://ow.ly/BG0M50ZOR0M

#CardioSky
September 24, 2026 at 5:00 PM
🔬Catch up on the latest #InterventionalCardiology #research in #JSCAI. The November issue is now available.

Explore the latest edition ➡️ https://www.jscai.org/current
November 18, 2025 at 8:01 PM
🧐 Where can you find the latest original #InterventionalCardiology research and practical insights? In the June issue of JSCAI! ➡️ https://www.jscai.org/current

#CardioSky
June 18, 2026 at 5:00 PM
🫀 Explore evolving approaches to #PulmonaryEmbolism in a new JSCAI Editor-in-Chief curated collection from Alexandra J. Lansky, MD, MSCAI. Discover evidence and clinical insights on PE diagnosis, risk stratification and interventional management ➡️ https://www.jscai.org/Pulmonary-Embolism

#CardioSky
September 6, 2026 at 2:00 PM
SCAI reappoints Alexandra J. Lansky, MD, MSCAI, to a second term as Editor-in-Chief of JSCAI. Under her leadership, the journal has expanded its global reach, achieved PubMed Central indexing, and surpassed 1M+ views/downloads.

Learn more ➡️ https://ow.ly/unzI50YFIFA

#CardioSky
April 14, 2026 at 5:00 PM
🛡️Today #RadiationSafety Takes Center Stage in #JSCAI

7 articles released on protecting physicians, staff, & pts - a new @scainews.bsky.social statement, the #ATTENUATE Trial, & Arizona's bold legislative approach to #radiation protection & safer working environments. Read more

🔗 jscai.org/inpress
July 14, 2026 at 6:44 PM
New in JSCAI: One-year results from the J-Valve Transfemoral Early Feasibility Study showed favorable outcomes in patients with symptomatic severe aortic regurgitation treated with the investigational J-Valve Transfemoral System. https://www.jscai.org/article/S2772-9303(26)01256-1/fulltext
July 1, 2026 at 12:01 PM
Our JSCAI article highlights all of the Occupational Hazards in the Cath lab. We can do better and we must do better. We should not have to sacrifice our own health for the good of others. @SCAI @Herms2James @AbudayyehIslam

www.sciencedirect.com/science/arti...
March 4, 2025 at 1:12 PM
📰 A new SCAI expert opinion document has been released exploring wire-free angiography-derived physiology (ADP) for coronary assessment. Learn when to use it, where it adds value, and where limitations remain.

Read the roundtable manuscript in #JSCAI ➡️ https://ow.ly/zvHB50Y6h6C

#CardioSky
February 3, 2026 at 6:45 PM
📖#AI #FFR, fully automated, machine learning–based tool, demonstrated high diagnostic accuracy compared with wire-based FFR. Read in #JSCAI 💡

🔗 www.jscai.org/article/S277...
Artificial Intelligence-Derived Fractional Flow Reserve in Routine Clinical Practice: An International Multicenter Retrospective Study
Artificial intelligence-based fractional flow reserve (AI-FFR) incorporates a machine learning-based algorithm to derive FFR directly from angiography. Its accuracy compared with invasive FFR has not ...
www.jscai.org
June 30, 2026 at 9:37 PM
#AlphaVac for RA masses in high-risk surgical pts. Safe, effective option in challenging cases. #CardioIntervention #Cardiosky #JSCAI

▶️https://www.jscai.org/article/S2772-9303(25)01606-0/fulltext
Management of Right-Sided Cardiac Masses With Manual Aspiration Using AlphaVac Device: A Single-Center Case Series
Right-sided cardiac masses pose therapeutic challenges, particularly in patients at high surgical risk. The AlphaVac mechanical aspiration system (AngioDynamics) provides a minimally invasive, endovas...
www.jscai.org
January 26, 2026 at 4:55 PM
In #JSCAI, @uclaradiology.bsky.social's Dr. @jonnymomd.bsky.social & collaborators profile 11,612 pulmonary embolism patients across 54 US sites, most at intermediate risk, in one of the largest real-world PE datasets yet. doi.org/10.1016/j.js...
doi.org
August 14, 2026 at 9:23 PM
💡 New from #JSCAI: Topical Collections make it easier to find the latest research, reviews, & expert perspectives on key areas in #IC. Explore now: https://www.jscai.org/content/collections

💠 #CardiogenicShock
💠 #PulmonaryEmbolism
💠 #IVL
💠 #Radiation
August 4, 2026 at 3:25 PM
Want to strengthen your academic CV?

The JSCAI Editorial Fellowship Program offers mentorship, publishing experience, and hands-on exposure to the editorial process.

Apply by Aug. 4.

https://ow.ly/OEkN50Zuj9y
August 2, 2026 at 1:00 PM
New from JSCAI: Curated Collections.
Explore some of the journal's most impactful papers on:
🔹 IVL
🔹 Cardiogenic Shock
🔹 Pulmonary Embolism
A quick way to access key evidence, clinical insights, and emerging trends shaping interventional cardiology. https://ow.ly/iNxn50ZsWcn
July 30, 2026 at 12:00 PM
What's new in #InterventionalCardiology? Discover the latest research, expert commentary, and clinical updates in the newest issue of JSCAI. Every article is free to read with Gold Open Access.

Explore the issue ➡️ https://jscai.org

#CardioSky
July 22, 2026 at 5:00 PM
New SCAI/ASE/HRS/SIR/SVS Expert Consensus Statement on Enhanced Radiation Protection calls for mandatory adoption of enhanced radiation protection in fluoroscopy labs—highlighting preventable risks and a path to safer practice.

Read the article in JSCAI ➡️ https://ow.ly/Ol5G50Zm3WE

#CardioSky
July 14, 2026 at 3:00 PM
Conavi Medical Announces JSCAI Publication Demonstrating the Clinical Utility of Hybrid IVUS OCT Imaging

Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies…
Conavi Medical Announces JSCAI Publication Demonstrating the Clinical Utility of Hybrid IVUS OCT Imaging
Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced the publication of a case report in the Journal of the Society for Cardiovascular Angiography & Interventions (“JSCAI”) titled “Versatility of Hybrid OCT and IVUS Imaging Enhances Contrast-Sparing Management of Eruptive Calcified Nodules.” The publication features Conavi’s hybrid intravascular ultrasound (“IVUS”) and optical coherence tomography (“OCT”) imaging system in a complex coronary procedure involving a patient with impaired renal function, where managing contrast exposure was an important consideration.
news-area.com
July 9, 2026 at 6:28 AM
🧐 What is it like to be a JSCAI Editorial Fellow? In our video, two fellows share how the program supported their career growth.

Watch the video ➡️ https://ow.ly/o33V50ZcoUP

Apply before August 4 ➡️ https://ow.ly/RPpw50ZcoUR

#InterventionalCardiology #CardioSky
July 8, 2026 at 12:00 PM
📰 #Finance

"Publication demonstrates how complementary IVUS and OCT information supports lesion assessment, treatment planning, and stent optimization while helping manage contrast use TORONTO, July 08, 2026 (GLOBE NEWSWIRE) — Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi”…"
Conavi Medical Announces JSCAI Publication Demonstrating the Clinical Utility of Hybrid IVUS OCT Imaging
financialpost.com
July 8, 2026 at 12:24 PM
Congratulations to the team at Johns Hopkins All Children's Hospital on their use of ŌNŌ to safely remove a malpositioned stent from a 4-mo-old infant with critical heart disease.

The youngest patient helped by ŌNŌ to date!

Read all about this extraordinary case in JSCAI:

lnkd.in/etJ-799T
September 26, 2025 at 8:07 PM